AbbVie Inc. Executive Compensation
AbbVie Inc. is an American publicly traded biopharmaceutical company founded in 2013.
Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
AbbVie Inc. discloses FY2025 compensation for 5 named executive officers, totaling $7.5M. Robert A. Michael, the Executive Officer, accounts for 43% of that combined total.
Robert A. Michael's total compensation rose 69% year-over-year, from $1.9M in FY2024 to $3.2M in FY2025.
Among 78 other Healthcare companies in this dataset, AbbVie Inc.'s combined tracked executive pay of $7.5M ranks in the 40th percentile (industry median: $13.6M). Its highest-paid executive, Robert A. Michael, ranks in the 26th percentile for top-executive pay in the sector (industry median: $6.3M).
Compensation figures on this page for AbbVie Inc. come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.